Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use

Journal of Psychoactive Drugs, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 12

Published: Feb. 7, 2025

The classic psychedelic psilocybin has attracted special interest across clinical and non-clinical settings as a potential tool for mental health. Despite increasing attention to challenging experiences, few studies have explored the relevance of shame-related processes with use. This prospective, longitudinal study involved sequential, automated, web-based surveys that collected data from 679 adults planning use in naturalistic at timepoints before after State trait shame feelings guilt were using validated measures assessed alongside other measurements psychological Acute or during experiences commonly reported (68.2% users) difficult predict. Ratings participant ability constructively work through these predicted wellbeing 2–4 weeks Psilocybin on average produced small but significant decrease was maintained 2–3 months (Cohen's dz = 0.37). Trait increased notable minority participants (29.8%). activation self-conscious emotions psychedelics deserves further experience subcategory may be relevant outcomes. Such could pose unique context-dependent learning condition both therapeutic detrimental forms memory reconsolidation.

Language: Английский

Editorial for psychedelic and psychedelic and psychedelic-like states

International Review of Psychiatry, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 6

Published: Feb. 13, 2025

Language: Английский